Featured Story | By Nick Paul Taylor Merz Therapeutics has opened another front in its effort to win market share from Botox. Spying a chance to differentiate itself through delivery in overactive bladder, Merz has partnered with Vensica Therapeutics for the needleless administration of its challenger to the blockbuster neurotoxin. read more |
| |
|---|
|
Top Stories By Nick Paul Taylor The race to treat nearsightedness in kids with low-dose atropine eye drops is heating up. Sydnexis is the latest company to make waves in the space, reeling in $45 million to fund phase 3 and selling the European rights to its candidate. read more By Nick Paul Taylor The flurry of business development activity at Aptar continues. Having made moves for injectable drug delivery and digital therapeutic players in recent weeks, Aptar has now nabbed an option on a high payload dry powder inhaler. read more By Nick Paul Taylor The brain is one of the final hiding places of HIV from combination antiretroviral therapy. Modern treatments effectively suppress levels of the virus in most parts of the body but struggle to cross the blood-brain barrier, allowing reservoirs to form in the central nervous system. The need to wipe out the reservoirs has spurred research into nanoparticles capable of entering the brain. read more By Andrea Park Baxter initiated the recall in July after a defect was discovered in its Dose IQ safety software, which could potentially cause it to transmit incorrect drug dosing information to Spectrum IQ infusion pumps. read more Resources Sponsored by: XIFIN inc. Download Frost & Sullivan’s enabling technologies best practices report to learn more about the four core functionalities required in successful precision medicine programs. Sponsored by: Patheon by Thermo Fisher Scientific Learn how a decentralized clinical trial strategy improves patient recruitment, reduces drop-out rates, and ultimately streamlines the path to the next trial phase. Sponsored by: Patheon by Thermo Fisher Scientific Learn how to build a robust packaging strategy and the key technical considerations in packaging design and operational planning to enable rapid commercialization of pharmaceuticals. Sponsored by: Patheon by Thermo Fisher Scientific Learn how regulations are changing and key considerations for commercializing cell and gene therapies without sacrificing quality. Sponsored by: LabVantage Solutions Uncover the real impact of “digital transformation” with practical advice to help you plan your own transformative journey to a harmonized digital ecosystem. Sponsored by: Box Read Get to Know Cloud Content Management for Life Sciences and learn how to eliminate silos across all workflows, from R&D to commercialization. Sponsored by: Catalent Discover the current state of patient-focused dose design through clinical evidence, real-world case studies and patient preference-driven drug design solutions that can help develop better treatments and successful real-world outcomes. Sponsored by: Catalent This eBook features insights from experts in the industry on patient-centric drug development challenges and strategies on advancing drug design and development effectively. Sponsored by: Catalent Learn about drug product process development challenges and risks, the difference between innovator and biosimilar drug product process development, and more during the drug product process development phase. Sponsored by: Remarque Systems Remarque Systems consolidates data, then layers on visualization and automated metrics to generate consistent, actionable data insights in real-time. Click here for more info. | 
